Aligned Genetics Inc
Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genet… Read more
Aligned Genetics Inc (238120) - Total Assets
Latest total assets as of September 2025: ₩45.11 Billion KRW
Based on the latest financial reports, Aligned Genetics Inc (238120) holds total assets worth ₩45.11 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Aligned Genetics Inc - Total Assets Trend (2015–2024)
This chart illustrates how Aligned Genetics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Aligned Genetics Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Aligned Genetics Inc's total assets of ₩45.11 Billion consist of 57.8% current assets and 42.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩1.81 Billion | 18.8% |
| Accounts Receivable | ₩2.89 Billion | 6.5% |
| Inventory | ₩4.20 Billion | 9.5% |
| Property, Plant & Equipment | ₩7.77 Billion | 17.6% |
| Intangible Assets | ₩131.53 Million | 0.3% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Aligned Genetics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aligned Genetics Inc's current assets represent 57.8% of total assets in 2024, a decrease from 84.5% in 2015.
- Cash Position: Cash and equivalents constituted 18.8% of total assets in 2024, down from 47.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 8.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 17.6% of total assets.
Aligned Genetics Inc Competitors by Total Assets
Key competitors of Aligned Genetics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Aligned Genetics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Aligned Genetics Inc generates 0.36x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Aligned Genetics Inc generates $9.32 in net profit.
Aligned Genetics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.05 | 17.95 | 13.07 |
| Quick Ratio | 8.13 | 14.10 | 11.34 |
| Cash Ratio | 0.00 | 1.94 | 0.00 |
| Working Capital | ₩23.63 Billion | ₩ 20.62 Billion | ₩ 14.72 Billion |
Aligned Genetics Inc - Advanced Valuation Insights
This section examines the relationship between Aligned Genetics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.66 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | ₩44.28 Billion |
| Market Capitalization | $21.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aligned Genetics Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Aligned Genetics Inc's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Aligned Genetics Inc (2015–2024)
The table below shows the annual total assets of Aligned Genetics Inc from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩44.28 Billion | +8.17% |
| 2023-12-31 | ₩40.93 Billion | +10.92% |
| 2022-12-31 | ₩36.90 Billion | +7.06% |
| 2021-12-31 | ₩34.47 Billion | +35.27% |
| 2020-12-31 | ₩25.48 Billion | +3.50% |
| 2019-12-31 | ₩24.62 Billion | +7.04% |
| 2018-12-31 | ₩23.00 Billion | -5.37% |
| 2017-12-31 | ₩24.31 Billion | -6.01% |
| 2016-12-31 | ₩25.86 Billion | +277.04% |
| 2015-12-31 | ₩6.86 Billion | -- |